Robitussin and Kapidex drug interactions - a phase IV clinical study of FDA data
Summary:
We study 4,501 people who take Robitussin (guaifenesin) and Kapidex (dexlansoprazole). There is no drug interaction reported.
The study analyzes what interactions people have when they take Robitussin and Kapidex. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Robitussin?
Robitussin has active ingredients of guaifenesin. eHealthMe is studying from 3,532 Robitussin users. Check the latest studies of Robitussin.
What is Kapidex?
Kapidex has active ingredients of dexlansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 969 Kapidex users. Check the latest studies of Kapidex.
No report is found.
Do you take Robitussin and Kapidex?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Robitussin (3,532 reports)
- Kapidex (969 reports)
How the study uses the data?
The study uses data from the FDA. It is based on guaifenesin and dexlansoprazole (the active ingredients of Robitussin and Kapidex, respectively), and Robitussin and Kapidex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Agrylin cause Thrombocytopenia? - 11 seconds ago
- Drug interactions of Azopt and Xopenex - 12 seconds ago
- Diabetes and Heart Palpitations - 29 seconds ago
- Drug interactions of Cranberry and Valacyclovir - 36 seconds ago
- Could Meclizine cause Blood Sodium Decreased? - 37 seconds ago
- Fever and Macular Degeneration - 41 seconds ago
- Could Indomethacin cause Fibromyalgia? - 51 seconds ago
- Metastases To Nervous System and Fatigue - a minute ago
- Drug interactions of Eylea and Candesartan Cilexetil - a minute ago
- Drug interactions of Amlodipine and Rozerem - a minute ago